AHMED ALI: Open Payments
NPI 1194887265 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 37 payments from 7 companies in 2025. Trend: 2023 $361 · 2024 $520 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $262 |
| AstraZeneca Pharmaceuticals LP | 9 | $197 |
| Lilly USA, LLC | 8 | $163 |
| ABBVIE INC. | 5 | $127 |
| PROTEGA PHARMACEUTIALS INC | 3 | $56 |
| Novo Nordisk Inc | 1 | $25 |
| Valinor Pharma, LLC | 1 | $18 |
Products named: RELISTOR, JARDIANCE, AIRSUPRA, QULIPTA, ROXYBOND, FARXIGA, Ozempic, MOVANTIK.
Industry payments across MO — which companies pay providers there.
